explore -WSS

explore

author：entertainment 2025-09-27 17:03:24 - browse：8516

A black and white cutout photo of Feng Zhang on the left of a black and white cutout photo of Alex Aravanis. Both photos are placed on top of yellow geometric shapes and a gradient dark blue background. — Researcher Feng Zhang, left, and Alex Aravanis, the CEO of Moonwalk. Illustration: Christine Kao/STAT; Photo: Katherine Taylor for STAT and Business Wire

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA strand.

Moonwalk Therapeutics launched Thursday with funding from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, Khosla Ventures, GV, and YK Bioventures. It plans to use that money to develop treatments for a variety of diseases, including chronic and aging-related conditions, using what’s called epigenetic editing.

Most of the gene editing technologies being used today slice or nick the DNA strand and make permanent changes to the biological building blocks of genes. Moonwalk, however, plans to alter the activity of genes by focusing on chemical changes. The company is targeting the surrounding chemicals that influence how genes act. This can be done through chemical processes methylation, which turns genes on, or demethylation, which turns genes off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Congress: Prevent baby formula shortages by passing a new bill

hotspot

WSS

Should insurance cover cosmetic surgery?

Guardant Health colon cancer test endorsed by FDA advisory panel

Shionogi licenses Pompe disease therapy from Maze Therapeutics

First recipient of genetically engineered pig kidney has died

Should insurance cover cosmetic surgery?

Use wet bulb globe temperature, not heat index, to protect workers

explore

explore

focus

Walensky prepares to leave CDC — and Congress — behind

J&J reports mixed data on next

Hepatitis C has a cure — but many Americans still lack access to it

Lawsuit challenges CMS nursing home minimum staffing rule

23andMe had bad news about my health. I wish a person had delivered it

Lawsuit challenges CMS nursing home minimum staffing rule

The cancer drug shortage isn’t new — and neither are the solutions

Congress: Prevent baby formula shortages by passing a new bill

Moonlake's readout produced a cash windfall. Risks remain

Researchers on aging grapple with how to calculate biological age

hotspot

Use wet bulb globe temperature, not heat index, to protect workers

Decentralized clinical trials need collaboration to achieve wider use

Pharma’s losing bet in New Jersey

First recipient of genetically engineered pig kidney has died

Beyond aggravation: Constipation is an American epidemic

Bird flu outbreak in cows is latest avian flu curveball

focus

hotspot

focus

Wikipedia